Company: INTS
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001567264-25-000010
Chunk: 13

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 16
Chunk 13
---
23Cash flows from operating activities:Net loss$(16,268)$(10,538)Adjustments to reconcile net loss to net cash used in operating activities:Amortization of discount on convertible notes- 159 Change in carrying value of right-of-use asset25 147 Stock-based compensation expense3,073 1,398 Stock issued in exchange for services51 - Loss on debt extinguishment- 2,262 Changes in operating assets and liabilities, net:Accrued interest on marketable debt securities(134)(197)Prepaid expenses, other current assets, and other assets301 (2,067)Accounts payable, accrued expenses and other liabilities(2,268)1,631 Net cash used in operating activities(15,220)(7,205)Cash flows from investing activities:Purchase of marketable debt securities(3,056)(15,053)Redemption of marketable debt securities9,410 9,030 Net cash provided by (used in) investing activities6,354 (6,023)Cash flows from financing activities:Proceeds from Registered Direct Offering3,000 - Issuance costs related to Registered Direct Offering(571)- Proceeds from ATM offering232 - Issuance costs related to ATM offering(82)- Proceeds from Initial Public Offering and overallotment- 22,425 Issuance costs related to Initial Public Offering and overallotment- (2,233)Proceeds from issuance of convertible note- 230 Proceeds from exercise of options and warrants321 50 Net cash provided by financing activities2,900 20,472 Net (decrease) increase in cash and cash equivalents(5,966)7,244 Cash and cash equivalents at beginning of period8,556 1,312 Cash and cash equivalents at end of period$2,590 $8,556 Supplemental disclosure of non-cash financing activities:Right-of-use lease asset and operating lease liability$- $155 Convertible notes issued in exchange for services$- 13 Conversion of convertible notes and accrued interest into common stock$- $4,737 Warrants issued in relation to issuance of convertible notes$- $159 Warrants issued to underwriter in connection with stock issuance$1,068 $1,170 Preferred stock deemed dividend$- $1,324 

The accompanying notes are an integral part of